The Motley Fool  writes…. Just a few weeks ago, the Oracle of Omaha, Warren Buffett, wrapped up another highly successful annual shareholder meeting for the conglomerate he’s run for decades, Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B). This event has become something of a mecca for investing enthusiasts, allowing them to listen to what one of the most successful buy-and-hold investors in the world has to say about the stock market, the economy, and other financial matters.

But just as investors have flocked to Buffett’s favorite stocks and industries for decades, they also take note when he shows skepticism toward a company, industry, or trend


Recently, he doubled down on his anti-cannabis rhetoric when asked by Fox Business Network anchor Liz Claman about the possibility of Coca-Cola getting into the marijuana industry. Said Buffett: “It would be a mistake for Coca-Cola to get into the marijuana-cannabis business. They have a wholesome image, and that would be detrimental to it.”

Yet, what you might find surprising is that of 47 separate securities that Berkshire Hathaway owned at the end of the first quarter, at least a handful of them already have some degree of marijuana industry exposure.

As noted by my Motley Fool colleague Jason Hall, nearly $95 billion of Berkshire’s $199 billion in total investments as of the end of the first quarter were in financial services companies, including big investments in Bank of America (NYSE:BAC)Wells Fargo (NYSE:WFC), and JPMorgan Chase (NYSE:JPM). As of this past weekend, Berkshire owned almost $25.5 billion worth of Bank of America stock, $18.7 billion worth of Wells Fargo stock, and $6.6 billion of JPMorgan Chase stock.

What makes these particular names stand out from the crowd is that in select U.S. states, they have been allowing marijuana businesses to set up checking and/or savings accounts, as well as gain access to basic banking services, which includes traditional loans and lines of credit.

According to a study released in early 2017 that was commissioned by the journal American Banker, 34% of businesses that filed to operate a medical marijuana dispensary in Massachusetts between June 2015 and September 2016 had a bank account with one of the United States’ big-four banks: Bank of America, Wells Fargo, JPMorgan Chase, or Citigroup, which is the only large bank Buffett’s Berkshire Hathaway doesn’t currently own. The study further notes that Bank of America appeared to be the most accommodating, with a little more than half of all medical cannabis applicants having an account with the bank.

This is an interesting finding given that cannabis is still a federally illicit (i.e., Schedule I) substance, and therefore most banks would be expected to avoid helping marijuana business altogether for fear of facing criminal prosecution and/or financial penalties. A banking bill working its way through Congress (the SAFE Banking Act) offers hope that new banking doors will open to the U.S. pot industry in the months and years to come.

The point here being that while the aggregate exposure in revenue dollars to the marijuana industry is likely very small, Buffett’s financial-services-heavy portfolio does have at least some cannabis exposure.

Read the full article at